Navigation Links
Scott & White Healthcare researchers studying investigational agent that targets breast cancer
Date:3/23/2010

Scott & White Healthcare researchers are studying an investigational agent that targets metastatic breast cancer to find if it can stop cancer cells from continuing to grow.

Breast cancer patients, whose disease has spread despite treatment, could be eligible to participate in a Phase II clinical trial to determine the efficacy of an investigational agent used to target the inner workings of cancer cells.

"At Scott & White, one of the things we can offer patients is our novel clinical trials," said Christopher O. Ruud, M.D., director of Scott & White's Breast Cancer Clinic. "By enrolling in this study, patients with metastatic breast cancer can help us learn what works in halting the growth of their cancer cells."

Dr. Ruud, along with Drs. Dan Hadlock, and Juan Posada of Scott & White, is involved in numerous studies targeting breast cancer. Their ultimate goal is to turn breast cancer into a manageable disease.

"Our goal is to help patients continue living a normal life," he said. "That is one of our strategies at Scott & White to find ways to treat breast cancer that has failed other treatments."


'/>"/>

Contact: Katherine Voss
kvoss@swmail.sw.org
254-724-4097
Scott & White Healthcare
Source:Eurekalert

Page: 1

Related medicine news :

1. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
2. SUNZ Insurance Company Selects Scott Robertson as President
3. James Scott Farrin Supports Radiothon for Duke Children's Hospital
4. Scott & White Healthcare pathologist is co-investigator on breast cancer study
5. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
6. Trustmark and HealthFitness Announce Early Termination of Hart-Scott-Rodino Waiting Period
7. Scott Roeder Trial: Randall Terry, Operation Rescue Founder and Insurrecta Nex Members to Attend Trial in Wichita
8. New study shows TGen spin-off boosts Scottsdale economy
9. Let Us Mute Our Praise for Scott Brown - a "Moderate" Child-Killer - and Seek to Replace Him With a True Pro-Lifer in Two Years, Says Randall Terry
10. Scott & White Healthcare researching treatments for rare cancers
11. Julian Lennon and James Scott Cook Release New Charity Single LUCY to Raise Awareness and Funds for Lupus Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- Grow Healthy Vending, LLC ... Joining the Grow Healthy Advisory Board team are Amanda Katchka, ... mission of our organization and bring talent, expertise and energy to ... continue to expand our footprint as the leader in healthy vending,” ...
(Date:5/24/2016)... ... May 24, 2016 , ... Physical therapy ... focuses on repairing the musculoskeletal and neuromuscular systems of the human body without ... NYDNRehab began providing treatments for physical therapy in New York, including dynamic ...
(Date:5/24/2016)... ... May 24, 2016 , ... Backed by decades of ... each job, ensuring the best suited solution to meet regulatory requirements. Their professional ... their lab in Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, the first independent, non-clinic ... its community and education hub for women considering fertility preservation, as well as ... safe and welcoming place for women to find cycle buddies, get clinic recommendations ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... advancing the science and clinical practice of radiosurgery, is recognizing five medical residents ... radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). The awards will be presented at ...
Breaking Medicine News(10 mins):
(Date:5/20/2016)... May 20, 2016 The Biotech ... believe that the industry is not far from recovering. ... ActiveWallSt.com featured the following four equities: Anacor Pharmaceuticals Inc. ... ATHX ), Aralez Pharmaceuticals Inc. (NASDAQ: ... INFI ). Sign up for your free trading alerts ...
(Date:5/19/2016)... 19,2016 Cellvizio Highlighted in ... Week Meeting and 91 st Congress of ... Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... announced that its Cellvizio platform is being highlighted ... during the month of May. The first meeting ...
(Date:5/19/2016)... , May 19, 2016 , The ... bstract # 8006)   The conclusions ... of the treated patients with 90% of the m ... months or more . Seventy two percent of the patients had ... announces the positive results from a Phase I study of plitidepsin in combination ...
Breaking Medicine Technology: